Pairwise comparisons from tumor volumes on day 11 (last day of experiment) also proved differences in tumor size between groups in both anti-PD-1 vs. TILT-517 + anti-PD-1 (p = 0.17) (Figure 7E) and anti-PD-L1 vs. TILT-517 + anti-PD-L1 (p = 0.00456) (Figure 7F). The gene discussed is CD274; the disease is neoplasm.